147 related articles for article (PubMed ID: 35454945)
1. Implication of COPB2 Expression on Cutaneous Squamous Cell Carcinoma Pathogenesis.
Chen T; Kim KY; Oh Y; Jeung HC; Chung KY; Roh MR; Zhang X
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454945
[TBL] [Abstract][Full Text] [Related]
2. Implication of Amyloid Precursor-like Protein 2 Expression in Cutaneous Squamous Cell Carcinoma Pathogenesis.
Huang X; Yang J; Xi H; Zhang M; Oh Y; Jin Z; Zheng Z
In Vivo; 2024; 38(1):399-408. PubMed ID: 38148084
[TBL] [Abstract][Full Text] [Related]
3. COPB2: A Novel Prognostic Biomarker That Affects Progression of HCC.
Zhang J; Wang X; Li G; He J; Lu Z; Yang Y; Jiang Y; Jiang L; Li F; Liu J
Biomed Res Int; 2021; 2021():6648078. PubMed ID: 33824874
[TBL] [Abstract][Full Text] [Related]
4. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
[TBL] [Abstract][Full Text] [Related]
5. Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway.
An C; Li H; Zhang X; Wang J; Qiang Y; Ye X; Li Q; Guan Q; Zhou Y
Int J Oncol; 2019 Apr; 54(4):1195-1208. PubMed ID: 30968146
[TBL] [Abstract][Full Text] [Related]
6. High expression of COPB2 predicts adverse outcomes: A potential therapeutic target for glioma.
Zhou Y; Wang X; Huang X; Li XD; Cheng K; Yu H; Zhou YJ; Lv P; Jiang XB
CNS Neurosci Ther; 2020 Mar; 26(3):309-318. PubMed ID: 31710183
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and Implications of Melanoma-associated Antigen A12 in Pathogenesis of Human Cutaneous Squamous Cell Carcinoma.
Zhao G; Bae JY; Zheng Z; Park HS; Chung KY; Roh MR; Jin Z
Anticancer Res; 2019 Apr; 39(4):1849-1857. PubMed ID: 30952725
[TBL] [Abstract][Full Text] [Related]
8. COPB2 Is Upregulated in Prostate Cancer and Regulates PC-3 Cell Proliferation, Cell Cycle, and Apoptosis.
Mi Y; Yu M; Zhang L; Sun C; Wei B; Ding W; Zhu Y; Tang J; Xia G; Zhu L
Arch Med Res; 2016 Aug; 47(6):411-418. PubMed ID: 27986120
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the Coatomer Protein Complex Subunit beta 2 (COPB2) Gene Targets microRNA-335-3p in NCI-H1975 Lung Adenocarcinoma Cells to Promote Cell Proliferation and Migration.
Pu X; Jiang H; Li W; Xu L; Wang L; Shu Y
Med Sci Monit; 2020 Jan; 26():e918382. PubMed ID: 32004259
[TBL] [Abstract][Full Text] [Related]
10. An Integrative Pan-Cancer Analysis of the Oncogenic Role of COPB2 in Human Tumors.
Wu B; Wu Y; Guo X; Yue Y; Li Y; He X; Chen Y; Zhao W; Liu J; Wu X; Shen A; Zhang S
Biomed Res Int; 2021; 2021():7405322. PubMed ID: 34676262
[TBL] [Abstract][Full Text] [Related]
11. The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma.
Zhu L; Cho E; Zhao G; Roh MR; Zheng Z
In Vivo; 2019; 33(2):393-400. PubMed ID: 30804117
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of COPB2 by RNAi inhibits growth of human cholangiocellular carcinoma cells.
Li ZS; Liu CH; Liu Z; Zhu CL; Huang Q
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):985-992. PubMed ID: 29509246
[TBL] [Abstract][Full Text] [Related]
13. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells.
Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y
Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272
[TBL] [Abstract][Full Text] [Related]
14. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
15. CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.
Zhang DW; Wu HY; Zhu CR; Wu DD
Int J Oncol; 2020 Aug; 57(2):478-487. PubMed ID: 32626939
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of COPB2 Promotes Prostate Cancer Proliferation and Invasion Through the MAPK/TGF-β Signaling Pathway.
Feng Y; Sun C; Zhang L; Wan H; Zhou H; Chen Y; Zhu L; Xia G; Mi Y
Front Oncol; 2022; 12():865317. PubMed ID: 35600351
[TBL] [Abstract][Full Text] [Related]
17. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
[TBL] [Abstract][Full Text] [Related]
18. Decreased TMEM40 expression is associated with malignant behavior of cutaneous squamous cell carcinoma and inhibits tumor progression.
Yu L; Liu J; Zhang TD; Zheng XF; Luo DL; Zhu WL; Qiu XW; Guo LL
Oncol Lett; 2021 Aug; 22(2):606. PubMed ID: 34188708
[TBL] [Abstract][Full Text] [Related]
19. lncRNA EZR‑AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway.
Lu D; Sun L; Li Z; Mu Z
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236153
[TBL] [Abstract][Full Text] [Related]
20. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
